Mechanical clot disruption for the treatment of acute basilar artery occlusion (BAO) is known to provide a benefit. We aimed to determine the safety, recanalization rate and time-toflow restoration of mechanical clot disruption and low dose urokinase (UK) infusions for the treatment of patients with acute BAO.
Introduction
Around 15% of ischemic strokes are caused by occlusion of the arteries in the posterior circulation. The prognosis of patients with posterior circulation stroke and basilar artery occlusion (BAO) is very poor with the mortality rate being over 80% [1] [2] [3] . If the patients are treated by intra-arterial thrombolysis (IAT), then the mortality rate decreases to 50% [2] [3] [4] [5] . More than half of the surviving patients regain functional independency in daily life 5 .
Dominant etiologic factors such as local thrombosis or artery-to-artery thromboembolism originating from atherosclerotic lesions account for >50% of BAOs 6, 7 . Other major etiolo-Abbreviation key BA = basilar artery BAO = basilar artery occlusion IA = intra-arterial IAT = intra-arterial thrombolysis IvT = intravenous thrombolysis mrs = modified rankin score NIHss = National Institutes of Health stroke scale PTA = percutaneous angioplasty TICI = thrombolysis in cerebral ischemia UK = urokinase study period, 24 patients underwent IAT combined with mechanical clot disruption. Among the 24 patients, three patients did not visit our institution after treatment and discharge from the hospital. finally, 21 patients were eventually included in this study. All patients in this study did not undergo IvT because we did not use Iv rt-PA in patients with more than three hours of symptom onset. One interventional neuroradiologist performed all the IAT procedures. Cerebral angiography and IAT were performed via a femoral approach. The initiation time of IAT was defined as when the needle puncture was done for the femoral approach. The angiographically determined occlusion sites were located in the proximal basilar artery, including the vertebrobasilar junction (n=8), the middle portion of the basilar artery (n=1) and the distal basilar artery (n=12). After demonstration of an occlusion on diagnostic angiography, an end-hole microcatheter (Excelsior sl-10; Boston scientific, Natick, Massachusetts, UsA) was advanced over a microguidewire (Transend-14; Boston scientific) through a 6f guide catheter into the occlusion site. The microcatheter tip was placed into the thrombus, and then a 100,000 U bolus of UK diluted to 10 ml in a mixture of saline and contrast medium (7:3) was manually infused for three to five minutes. We mixed the contrast medium for early detection of recanalization during UK infusion.
Mechanical clot disruption was undertaken after 100,000 U of UK was administered. We used mechanical clot maceration with a microcatheter and a microwire (Agility 10; Cordis, Miami lakes, fl, UsA) in all the patients. Mechanical clot maceration consisted of multiple passes of the microwire through the clot. The microwire was gently rotated clockwise while being advanced. During this process, the microcatheter was often advanced multiple times over the microwire as well. After withdrawal of the microwire from the microcatheter, an additional 100,000 U of UK was manually infused for three to five minutes through the microcatheter at the site of the remaining thrombus. We used the UK for IAT based on PrOACT-II study. The UK infusions were stopped immediately if the control angiograms showed complete recanalization. A reattempt at mechanical clot disruption using a microcatheter and a microwire was performed if recanalization was not achieved after UK infusion. The patients with distal migration of thrombus into the pos-gies are cardiac emboli and vertebral artery dissections. The outcome of acute BAO depends on the clinical state at presentation, the length and location of the occlusion, the degree of recanalization and the time to treatment 2,3,8-13 . for BAO, early recanalization is known to be one of the most important factors for a good outcome [8] [9] [10] . lindsberg and Mattle reported that the effect of intravenous thrombolysis (IvT) in patients with BAO was probably not very different from the effect of IAT 5 . However, in the absence of a direct comparative study, an estimated average recanalization rate of 70% for IAT may be superior to that of IvT [14] [15] [16] .
Mechanical clot disruption for the treatment of acute BAO has recently been shown to provide a benefit compared with IAT for ischemic stroke. Mechanical clot disruption was defined as the use of at least one of the following endovascular managements: (a) mechanical microcatheter and microwire clot maceration, (b) percutaneous angioplasty, (c) stent placement and (d) the use of a clot removal device. However, IAT and mechanical clot disruption in the posterior circulation (still need clinical trial based evidence). Therefore, we aimed to determine the safety, recanalization rate and timeto-flow restoration of mechanical clot disruption and low dose urokinase (UK) infusions for the treatment of patients with acute BAO.
Materials and Methods
This study received approval by the institutional research ethics board of the hospital. In addition, informed consent was obtained from the patients' families. from July 2006 to June 2010, the consecutive patients who underwent treatment with low dose intra-arterial (IA) UK combined with mechanical clot disruption for BAO were retrospectively enrolled in this study. On admission, the National Institutes of Health stroke scale (NIHss) scores were assessed by a stroke neurologist. Either cerebral CT or Mr was obtained for all the patients before initiation of IA treatment. The inclusion criteria of this study were the followings: 1) posterior circulation stroke symptoms within 12 hours before treatment, 2) CT or Mr exclusion of hemorrhage and 3) BAO confirmed by IA digital subtraction angiography and this was treated by mechanical clot disruption with lowdose IA UK. The exclusion criteria included patients who were lost to follow-up. During the blinded to the treatment. A brain CT scan was routinely obtained immediately after the procedure and if the patients showed neurologic deterioration during admission. The CT scans were analyzed for hemorrhagic transformation by the same interventional neuroradiologist. The clinical outcome was assessed by the modified rankin scale (mrs) at three months and this was dichotomized as favorable (mrs, 0-2) or unfavorable (mrs, [3] [4] [5] [6] .
Results
Twenty one patients with acute BAO (6 women and 15 men) with a median age of 68.6 years (range: 47 - 87 years) met the study criteria. The clinical characteristics of the 21 patients are summarized in Table 1 . The median NIHss score was 13.2 (range: 2-33) on admission. Median time from symptom onset to arrival at hospital was 356 minutes, and median time from symptom onset to intra-arterial thrombolysis (IAT) was 49 minutes). The median IA treatment duration was 82 minutes (range: 40-140) and the UK dose was 50,000 -400,000 U (median: 250,000U). Of these patients, six patients received an additional injection of UK due to distal migration of thrombus into the posterior cerebral artery (100,000 -200,000 U). four patients had severe stenosis of the basilar artery after UK infusion and mechanical clot disruption with a microcatheter and microwire. Of these patients, three received stent placement after angioplasty (figure 1) and one underwent only angioplasty. Three patients had a mural thrombus remaining in the basilar artery after mechanical clot disruption with a microcatheter and microwire, and so mechanical clot disruption with a Hyperform compliant balloon catheter was performed. recanalization (TICI grade II or III) was achieved in 19 patients (90.5%). Twelve patients (57.1%) were TICI grade III and seven patients (33.3%) TICI grade II. Two patients (9.5%) (TICI grade I) failed with recanalization of the posterior circulation. Of these patients, one patient had treatment due to a procedure-related subarachnoid hemorrhage and one had a diffuse, long segmental stenosis of the basilar artery. There was symptomatic hemorrhage in one patient.
Two patients (9.5%) died within one week after the procedure. One patient with hemorrhage complication died and one with incomplete recanalization due to a long segmental terior cerebral artery were additionally infused with 100,000 U of UK through a microcatheter at the site of the occluded artery. The patients who did not achieve complete recanalization after mechanical clot disruption using a microcatheter and a UK infusion underwent percutaneous angioplasty or/and stent placement about the severe stenosis of the vertebrobasilar artery. Percutaneous angioplasty with a coronary balloon catheter (Ma'sla Just; Asahi, Aichi, Japan) or a Hyperform compliant balloon (MicroTherapeutics, Irvine, CA, UsA) was carried out in seven patients. The diameter of the coronary balloon was chosen to be 0.5 mm smaller than that of the adjacent portion of the occluded segment. The diameter of the Hyperform compliant balloon was 4×7 mm. Three patients with severe stenosis after angioplasty underwent deployment of a balloon-expandable stent (Jostent; Abbott laboratories, Abbott Park, Il, UsA). The stent was similar in size to the diameter of the normal patent vessel. The stent length was selected to be equal to or exceed the length of a target lesion. Before stent placement, clopidogrel (225-300 mg) was orally administered through an orally placed gastric tube to prevent acute stent thrombosis for those patients who were not pretreated with adequate antiplatelet medications. The patients received a maintenance dose of either aspirin (100 mg daily) or clopidogrel (75 mg daily) from the next day after the procedure.
Pre-treatment and post-treatment angiograms were evaluated by the same interventional neuroradiologist. The recanalization status was classified according to the Thrombolysis in Cerebral Ischemia (TICI) scale (grade 0: no perfusion, grade I: penetration but not perfusion, grade IIa: partial perfusion with incomplete distal filling of <50% of the expected territory, grade IIb: partial perfusion with incomplete distal filling of 50%-99% of the expected territory, grade IIc: nearly complete perfusion but with a delay of the contrast runoff, grade III: full perfusion with normal filling of the distal branches in a normal hemodynamic fashion). recanalization was defined as TICI grades II or III.
Age, gender, the NIHss on admission, the time from symptoms to IA therapy, duration of the procedure, the UK dose, recanalization, symtomatic intracranial hemorrhage, the NIHss at discharge and the outcomes were recorded and analyzed. The clinical evaluation was done by stroke neurologists who were not was noted in 75% of the patients. Mechanical clot disruption could decrease the symptomatic intracranial hemorrhage compared with that of pharmacologic IvT-IAT. symptomatic intracranial hemorrhage is the most feared complication of combined IvT-IAT. Previous studies of IAT with UK suggest a higher dose of IA UK leads to higher rates of symptomatic intracranial hemorrhage 21, 22 . In our study, we used a minimal amount of urokinase, and we also used the technique of mechanical clot disruption. In this study, only one patient displayed symptomatic hemorrhage (4.7%).
Most of the recent national guidelines favor endovascular thrombolysis in combination with mechanical manipulation of the thrombus. A recent meta-analysis on the therapy for BAO showed that notwithstanding better recanalization after IA therapy, the survival rates after Iv and IA thrombolysis were comparable 5 . A multicenter observational study has recently shown that the bridging concept, when used as combined treatment with IA rt-PA and Iv platelet glycoprotein IIb/IIIa receptor inhibitors and additional percutaneous transluminal angioplasty/stenting in cases of severe residual stenosis after IAT, might improve the neurologic outcome compared to IAT with rt-PA alone 23, 24 . Pfefferkorn T. et al. 25 reported a high recanalization rate after Iv thrombolysis and on-demand consecutive endovascular mechanical thrombectomy using an Amplatz goose neck snare and an Angiojet in patients with acute BAO.
In our study, four patients were treated with additional mechanical thrombectomy for their residual thrombi after mechanical clot disruption with a microcatheter and microguidewire, and three patients received stenting after percutaneous angioplasty for treating the underlying atherosclerotic stenosis.
Therefore, combined mechanical thrombectomy and IAT with low-dose UK is efficient in patients with acute BAO (90.5%, 19/21). These recanalization rates are within the range of 44% to 100% reported in the previous case series and large observational studies and they are mildly superior to the rate of a recently comparable study (72-83.7%) 23, 24 .
A favorable outcome was noted in 66.7% of our patients, with a 4.7% rate of symptomatic cerebral hemorrhage and a mortality rate of 14.3%.
The limitations of our study include the lack of central adjudication of events and cerebral stenosis and an initial comatose mental status died. At discharge (19/21), the median NIHss score was 6.3 (range: 0-27). The NIHss score of 17 patients had improved. In two patients, the NIHss score was increased. At the threemonth follow-up, the functional outcome was favorable (mrs, 0-2) in 14 (66.7%) out of the 21 patients. The functional outcome was unfavorable (mrs, 3-6) in seven (33.3%) patients and among them three (14.3%) patients, including the two patients who died after their procedures, died within the three-month follow-up time frame.
Discussion
Basilar artery occlusion (BAO) is the most severe form of ischemic stroke and it has high mortality and morbidity rates. Despite all the advances in modern therapy and general medical care, the prognosis is still grim. Early recanalization has been shown to be the most important predictor of successful therapy [8] [9] [10] . The absence of well-balanced comparative studies of the literature-based outcomes or a large prospective randomized trial has led to a different view on the preferred therapy, that is, IvT or IAT. lindsberg et al. 17 reported a 52% recanalization rate after Iv rtPA in patients with BAO. However, several series have reported rates of recanalization with IAT that were thought to be higher than that for IvT 4, [14] [15] [16] .
We performed the IAT with low-dose IA UK and mechanical clot disruption using a microcatheter and microguidewire in all the patients. Mechanical clot disruption by the use of a microcatheter/microguidewire and/or percutaneous angioplasty can provide an advantage compared with IA infusion by increasing the recanalization rate and speed and reducing the total thrombolytic dose [18] [19] [20] . Noser et al. 18 reported a 38% immediate recanalization rate in 32 patients with acute ischemic stroke and who were treated with mechanical clot disruption in conjunction with IA infusion of reteplase. Of the 32 patients, 22 received combined IvT-IAT. A favorable outcome was noted in 59% of the patients, with a rate of symptomatic cerebral hemorrhage of 9.4% and a mortality rate of 12.5%. yoon et al. 20 reported a 100% recanalization rate in 12 patients with acute ischemic stroke and who were treated with mechanical clot disruption and low-dose IA UK after failure of IvT. A favorable outcome
